DB959: Phase Ib started

Dara BioSciences began a double-blind, placebo-controlled, U.S. Phase Ib trial

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE